Table 1.
Cell line | Control | Epirubicin concentration | ||
---|---|---|---|---|
MDA-MB-231 | DMSO | 1 nM | 25 nM | 1000 nM |
Native | 18 % | 17 % | 41 % | 94 % |
25 nM-R | 10 % | 10 % | 8 % | 50 % |
MCF7 | DMSO | 1 nM | 30 nM | 1000 nM |
Native | 32 % | 29 % | 49 % | 77 % |
30 nM-R | 20 % | 24 % | 23 % | 78 % |
SKBR3 | DMSO | 1 nM | 15 nM | 1000 nM |
Native | 22 % | 26 % | 24 % | 59 % |
15 nM-R | 18 % | 17 % | 17 % | 34 % |
ZR-72-1 | DMSO | 1 nM | 10 nM | 1000 nM |
Native | 36 % | 44 % | 47 % | 71 % |
10 nM-R | 29 % | 28 % | 29 % | 62 % |
DMSO dimethyl sulphoxide; DRFS, distant relapse-free survival
Apoptotic cells = annexin V–positive. Debris and necrotic cells (annexin V–negative, 7-aminoactinomycin D–positive) were gated out. Percentages reported are derived from a single experiment; at least two independent experiments were done for each cell line
Bold data denotes the different concentrations of epirubicin used for each cell line